University of Florida Wins 2023/24 Certara-Simcyp™ Grant and Partnership Scheme Announcement University of Florida Wins 2023/24 Certara-Simcyp™ Grant and Partnership Scheme RADNOR, PA — July 3, 2024 - Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraJuly 3, 2024
Phoenix UGM Europe 2024 Live Events Phoenix UGM Europe 2024 Join the worldwide Phoenix user community and the Certara Phoenix team to learn how our…CertaraJune 28, 2024
Categorizing & Managing Risks in Aggregate Safety Reports Blog Categorizing & Managing Risks in Aggregate Safety Reports Categorizing Risks From a sponsor’s first authorization to conduct a clinical drug trial in any…CertaraJune 28, 2024
pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization Publication pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization Dr. Mark Sale, Dr. Keith Nieforth, James Craig and peers from industry, healthcare, and academia…CertaraJune 28, 2024
How AI-powered writing software can bring a benefit in Japan [Japan Webinar] On-Demand Webinar How AI-powered writing software can bring a benefit in Japan [Japan Webinar] This webinar will be held in Japanese only. Medical writing is a critical part of…CertaraJune 27, 2024
Catalyzing DMTA Information into Insights On-Demand Webinar Catalyzing DMTA Information into Insights Drug discovery is a data-driven research process that requires accurate data capture, ample and reliable…CertaraJune 27, 2024
Future Clinical Study Design: CDISC, FHIR, OMOP, or Hybrid Model? Blog Future Clinical Study Design: CDISC, FHIR, OMOP, or Hybrid Model? June 27, 2024 Advances in technology and changes to the regulatory environment have resulted in…CertaraJune 27, 2024
Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain Publication Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain CertaraJune 26, 2024
Adopting the Power of AI to Drug Development Projects: Making go/no-go decisions with MBMA and CODEx Clinical Outcome database Press Coverage Adopting the Power of AI to Drug Development Projects: Making go/no-go decisions with MBMA and CODEx Clinical Outcome database CertaraJune 26, 2024
Generative AI Tools for Regulatory Writing Blog Generative AI Tools for Regulatory Writing Regulatory writing is a crucial component of the drug development process. Regulatory writers must understand…CertaraJune 20, 2024